ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $31,392 | -25.3% | 28,800 | 0.0% | 0.02% | -28.0% |
| Q4 2022 | $42,048 | +5.1% | 28,800 | -21.7% | 0.02% | -51.9% |
| Q3 2022 | $40,000 | -43.7% | 36,800 | -12.0% | 0.05% | -32.5% |
| Q2 2022 | $71,000 | -80.8% | 41,800 | -57.5% | 0.08% | -64.7% |
| Q4 2021 | $369,000 | -28.6% | 98,450 | -1.5% | 0.22% | -31.9% |
| Q3 2021 | $517,000 | +123.8% | 99,950 | +84.2% | 0.32% | +128.6% |
| Q2 2021 | $231,000 | +16.1% | 54,250 | +45.1% | 0.14% | -0.7% |
| Q1 2021 | $199,000 | +111.7% | 37,400 | +113.7% | 0.14% | +58.4% |
| Q4 2020 | $94,000 | – | 17,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |